Genmab A/S (ETR:GE9)
246.00
-0.30 (-0.12%)
At close: Nov 7, 2025
Genmab Revenue
Genmab had revenue of $1.02B USD in the quarter ending September 30, 2025, with 23.34% growth. This brings the company's revenue in the last twelve months to $3.85B, up 29.57% year-over-year. In the year 2024, Genmab had annual revenue of $2.99B with 22.32% growth.
Revenue (ttm)
$3.85B
Revenue Growth
+29.57%
P/S Ratio
4.65
Revenue / Employee
$1.43M
Employees
2,682
Market Cap
15.24B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.99B | 545.24M | 22.32% |
| Dec 31, 2023 | 2.44B | 358.99M | 17.23% |
| Dec 31, 2022 | 2.08B | 796.62M | 61.88% |
| Dec 31, 2021 | 1.29B | -374.23M | -22.52% |
| Dec 31, 2020 | 1.66B | 855.79M | 106.20% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Mercedes-Benz Group AG | 136.97B |
| Bayerische Motoren Werke Aktiengesellschaft | 136.42B |
| Deutsche Telekom AG | 120.55B |
| Allianz SE | 109.02B |
| Deutsche Post AG | 84.05B |
| Siemens Aktiengesellschaft | 78.30B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.33B |
| Siemens Energy AG | 38.39B |
Genmab News
- 1 day ago - Genmab A/S (GMAB) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 days ago - Genmab AS (GMAB) Q3 2025 Earnings Call Highlights: Robust Revenue Growth and Strategic ... - GuruFocus
- 3 days ago - Q3 2025 Genmab A/S Earnings Call Transcript - GuruFocus
- 3 days ago - Genmab Nine-Mont Profit Rises - Nasdaq
- 3 days ago - Genmab (GMAB) Expects Revenue Boost by 2025 Due to Increased Sales and Collaborations - GuruFocus
- 4 days ago - Genmab to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference in London - GlobeNewsWire
- 4 days ago - Genmab Q3 2025 Earnings Preview - Seeking Alpha
- 4 days ago - Genmab AS (GMAB) Q3 2025 Earnings Report Preview: What To Look For - GuruFocus